Using brain stimulation to help patients with autoimmune muscle diseases
Official title: Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
Run by University of Sao Paulo · NCT04678635 · Data updated 2026-11-12
This study is testing if a new brain stimulation treatment combined with exercise can help people with autoimmune muscle diseases feel stronger and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Sao Paulo Academic / other |
| Locations | 1 site (São Paulo, São Paulo) |
| Status | Recruiting |
| Started | December 12, 2020 |
| Main results expected | May 6, 2024 |
| Study ends | December 4, 2024 |
| Registry record updated | December 9, 2024 |
| Trial ID | NCT04678635 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with systemic autoimmune myopathies who meet specific classification criteria.
✕Probably not a fit
Patients with neoplasia, heart pacemakers, visceral metallic clips, infections, pregnancy, or a history of seizures or epilepsy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and efficacy of chronic transcranial direct current stimulation combined with aerobic exercises in patients suffering from systemic autoimmune myopathies. These conditions lead to significant muscle weakness and functional disability, and the study aims to explore a novel therapeutic approach that has not been previously tested in this patient population. It is a prospective, randomized, double-blind, placebo-controlled design, ensuring rigorous assessment of the intervention's effects. The goal is to determine if this technique can improve muscle function and overall quality of life for affected individuals.
Why it matters
Potential benefit: If successful, this approach could significantly enhance muscle recovery and functional ability in patients with systemic autoimmune myopathies.
How similar studies have gone: While transcranial direct current stimulation has shown promise in other conditions, this specific application in systemic autoimmune myopathies is novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Classification criteria - EULAR/ACR 2017 * Classification critera - Connors et al. Exclusion Criteria: * Neoplasia * Using heart pacemarker * Using visceral metalic clips * Infections (HIV, HTLV-1, Hepatitis, etc) * Pregnance * Previous historical of convulsions or epilepsies
Where it's running
-
Samuel K Shinjo
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Principal investigator: Samuel K Shinjo — Brazil
- Study coordinator: Samuel K Shinjo, PhD
- Email: samuel.shinjo@usp.br
- Phone: 55113061-7176
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Natural history documentation of TNNT1 myopathy
This study is trying to learn more about how TNNT1 myopathy affects people over time to help improve future treatments.
-
Imaging markers for bulbar involvement in inclusion body myositis among IBM and comparison groups
This study tests whether ultrasound and MRI can detect swallowing and bulbar muscle problems in people with inclusion body myositis.
-
Measuring muscle health with a handheld electrical impedance device (mScan)
This project will test whether a handheld mScan device can quickly measure muscle health in adults with myopathies and in people without muscle disease by comparing its readings to MRI.
-
Using muscle relaxants to improve electroporation ablation safety
This study tests if using muscle relaxants during a heart procedure called electroporation ablation can make it safer for patients and help them recover faster.
-
Effects of annatto-derived GG on muscle health in statin users
This study is testing if a supplement made from annatto can help people over 40 who have muscle pain from taking statins feel better after three months.
-
Using brain stimulation to treat muscle weakness in autoimmune myopathy patients
This study is testing if a new type of brain stimulation can help people with autoimmune myopathy improve their muscle strength and overall health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.